Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-021329
Filing Date
2025-02-14
Accepted
2025-02-14 16:40:36
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 5 ownership.html 5  
1 5 ownership.xml 5 8725
  Complete submission text file 0000950170-25-021329.txt   10126
Mailing Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address
BELANOFF JOSEPH K (Reporting) CIK: 0001286199 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-50679 | Film No.: 25630040